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Trayhurn P. Hypoxia and Adipose Tissue Function and Dysfunction in Obesity. Physiol
Rev 93: 1–21, 2013; doi:10.1152/physrev.00017.2012.—The rise in the incidence
of obesity has led to a major interest in the biology of white adipose tissue. The tissue
is a major endocrine and signaling organ, with adipocytes, the characteristic cell type,
secreting a multiplicity of protein factors, the adipokines. Increases in the secretion of
a number of adipokines occur in obesity, underpinning inflammation in white adipose tissue and the
development of obesity-associated diseases. There is substantial evidence, particularly from animal
studies, that hypoxia develops in adipose tissue as the tissue mass expands, and the reduction in
PO2 is considered to underlie the inflammatory response. Exposure of white adipocytes to hypoxic
conditions in culture induces changes in the expression of 1,000 genes. The secretion of a
number of inflammation-related adipokines is upregulated by hypoxia, and there is a switch from
oxidative metabolism to anaerobic glycolysis. Glucose utilization is increased in hypoxic adipocytes
with corresponding increases in lactate production. Importantly, hypoxia induces insulin resistance
in fat cells and leads to the development of adipose tissue fibrosis. Many of the responses of
adipocytes to hypoxia are initiated at PO2 levels above the normal physiological range for adipose
tissue. The other cell types within the tissue also respond to hypoxia, with the differentiation of
preadipocytes to adipocytes being inhibited and preadipocytes being transformed into leptin-secret-
ing cells. Overall, hypoxia has pervasive effects on the function of adipocytes and appears to be a
key factor in adipose tissue dysfunction in obesity.
I. INTRODUCTION 1
II. OVERVIEW OF ADIPOSE TISSUE 2
III. HYPOXIA IN ADIPOSE TISSUE 4
IV. HYPOXIA AND ADIPOCYTE GENE... 6
V. SUBSTRATE AND GENERAL METABOLISM 8
VI. THE SIGNIFICANCE OF DIFFERING... 11
VII. HYPOXIA AND THE... 12
VIII. CONCLUDING COMMENTS 13
I. INTRODUCTION
Historically, white adipose tissue, or white fat, has been
viewed as one of the least complex organs in the body. The
central perspective for many years was that of a simple fat
storage organ in which excess calories are deposited after a
meal and from which fuel is released during fasting and
prolonged food deprivation. As a consequence, much of the
early biochemical interest in adipose tissue centered on the
regulation of fat synthesis and breakdown, through lipo-
genesis and lipolysis, respectively (201). The apparent met-
abolic simplicity was paralleled by a sense that the morphol-
ogy of the tissue was also simple, with mature adipocytes
being the overwhelmingly dominant cell type. This struc-
tural simplicity appears very evident in standard histologi-
cal sections of white fat. However, over the past 15–20
years, our views of white adipose tissue and its biological
functions have changed radically, and apparent simplicity
has been replaced by ever-growing complexity. The com-
plexity has been compounded by recent developments
which have indicated that a clear distinction between white
and brown adipose depots is itself simplistic.
The major driver behind the growth in interest in white
adipose tissue has been the increasing concern with obesity
and its implications for public health. In both advanced and
developing economies, obesity has become a major health
problem. In the United Kingdom, for example (which has
one the highest obesity rates in Europe), 25% of adults
are clinically obese (162), while in the United States the
incidence is as high as one-third of the adult population
(138). These figures are based on the definition of obesity of
a body mass index (BMI) of 30 or more. It is not obesity per
se, however, that represents the medical problem, but rather
the diseases with which it is associated, and these include
insulin resistance and type 2 diabetes, cardiovascular dis-
ease, and certain cancers (3, 9, 103, 217a). In the case of
type 2 diabetes, the risk of developing this particular obesity-
related disorder is increased at least 10-fold in men (and
more in women) in those with a BMI of 30, relative to those
of ideal weight (103, 105). Obesity is, of course, character-
ized by a substantial increase in white adipose tissue mass,
with BMI being a proxy for body fat content. In lean adults
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(men), some 15–20% of total body composition is due to
adipose tissue, and this increases to 40% and more in the
obese. Thus adipose tissue is quantitatively a very major
organ in both lean and obese individuals, and as such a
priori would be expected to have a substantial impact on
metabolic regulation and whole body physiology.
There have been several pivotal developments that have
revolutionized our understanding of white adipose tissue
function. The most significant and far-reaching is the rec-
ognition, initiated by the discovery of leptin in 1994 (232),
that white adipocytes are major endocrine cells that secrete
a diverse range of protein signals and factors (52, 158, 167,
193, 194). Another key development is the realization that
adipose tissue depots become “inflamed” in obesity, with
the view that the inflammatory state leads to the initiation
and progression of the major obesity-associated diseases (3,
9, 81, 167, 228). In this review, the concept, which was first
advanced in 2004 (198), that white adipose tissue becomes
hypoxic as adipocyte size and tissue mass expand in obesity,
and that this underlies the development of inflammation
and cellular dysfunction, is considered. The basis for adi-
pose tissue hypoxia in the obese state is discussed, together
with the accumulating evidence that low oxygen tension has
extensive effects on white adipocytes with important impli-
cations for adipose tissue functionality in obesity.
II. OVERVIEW OF ADIPOSE TISSUE
A. Cellular Complexity
Before addressing the specifics of hypoxia in adipose tissue,
it is important to first consider the extent of the complexity
of the tissue. Traditionally, adipose tissue has been consid-
ered to be composed of two distinct forms, white and
brown, with fundamentally different functions. Brown ad-
ipose tissue is specialized for the generation of heat by non-
shivering mechanisms, fuelled primarily by the oxidation of
fatty acids, through the presence of a specific mitochondrial
“uncoupling protein,” UCP1 (uncoupling protein-1), which
dissipates the proton gradient across the inner mitochon-
drial membrane (19, 74, 134, 163). The generation of heat
by brown adipose tissue may be evoked for thermoregula-
tory purposes to enable the maintenance of body tempera-
ture, or for the arousal from hibernation (19, 134). Brown
adipose tissue thermogenesis also enables the dissipation of
excess calories as a mechanism for the maintenance of en-
ergy balance, or body weight (19, 20, 75, 168, 169, 192).
White adipose tissue, on the other hand, is specialized for
fuel storage rather than for the oxidation of stored fatty
acids, providing substrate to other tissues such as muscle
during fasting and periods of high energy demand. Classi-
cally, lipid was considered to be deposited in a single unil-
ocular droplet within white adipocytes, with multiple drop-
lets in the case of brown fat cells.
It has been argued that it is appropriate to consider the
brown and white forms of adipose tissue as comprising a
single “adipose organ” (28, 29). Trans-differentiation be-
tween brown and white adipocytes has been part of the
argument for a single organ (30, 203). However, the view
has been challenged by recent evidence that brown adi-
pocytes, in contrast to white, are derived from myogenic
progenitor cells (173, 190). The concept of two distinct
forms of adipose tissue has also been challenged through the
recognition that some fat depots have both white and
brown adipocytes, and by the identification of a third form
of fat cell, the “brite” adipocyte. These brite cells express
UCP1, but do not possess the complete molecular charac-
teristics of brown adipocytes (154, 205). Brite-rich depots
can be identified by their combined expression of UCP1 and
Hoxc9 (homeobox 9), while Zic1 (zinc finger protein in the
cerebellum 1) rather than UCP1 is a unique marker of clas-
sical brown adipose tissue depots (205). Tcf21 (transcrip-
tion factor 21), together with the absence of expression of
UCP1, Zic1, Tbx15 (T-box protein 15), and Shox2 (short
stature homeobox 2), can be used to differentiate white
adipose depots from brown or brite (205). With the use of
these molecular markers, the various adipose tissue depots
can be categorized; depots such as the interscapular adipose
tissue (and cardiac) of rodents appear to be essentially
“brown,” while the epididymal depot is strongly “white”
(205).
In addition to different forms of adipocyte, several types of
nonadipocyte cell are present in white adipose tissue depots
(the focus of this review hereafter is white adipocytes and
the essentially white fat depots) (71). These include fibro-
blastic preadipocytes, the precursor cells of white adi-
pocytes. Adipose tissue also contains vascular endothelial
cells, macrophages, and mast and dendritic cells. Macro-
phages are regarded as being particularly important in the
inflammatory response that occurs in the tissue as obesity
develops, and the obese state is associated with a major
recruitment of these cells (17, 211, 220). In practice, several
types of immune cell are present in adipose tissue in addi-
tion to macrophages, including lymphocytes, natural killer
(NK) cells, and mast cells. Mast cells may be of particular
importance to the innate immune response within the tissue
(115). Increased infiltration of NK cells and T cells, as well
as of macrophages, is evident in adipose tissue of obese
subjects (137, 159).
White adipose tissue is innervated by sympathetic nerve
endings, the sympathetic system being the principal physi-
ological mediator of lipolysis (66, 183) with marked acti-
vation occurring in situations where there is net lipolysis
(54, 128). The extent of the sympathetic innervation in
white fat is less than that of brown adipose tissue (28). In
brown fat, the sympathetic system plays a central role in the
initiation and regulation of thermogenesis, including mito-
chondrial biogenesis and the recruitment of UCP1 (19, 75,
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76). The proportion of the total cell content of white adi-
pose tissue due to mature adipocytes varies between depots,
ranging from 30–50% (71). Thus, despite the gross his-
tological appearance, white adipose tissue is not composed
overwhelmingly of white adipocytes, in most cases these
cells comprising less than half the total cellular content.
Nonetheless, adipocytes are the signature cell of adipose
tissue and have been the primary focus of cellular studies on
the tissue, including of hypoxia. During cell fractionation,
the mature adipocytes are separated from the nonadipocyte
cells, which constitute what is known as the stromal-vascu-
lar fraction.
B. Secretory Role of White Adipocytes:
Adipokines
White adipocytes are major secretory cells, releasing a mul-
tiplicity of lipid and protein entities in addition to the stored
fatty acids that are mobilized on lipolysis (52, 158, 193,
194). The lipid secretions include cholesterol and specific
prostaglandins, such as PGE2 and 15-deoxy-PGJ2 (4, 44,
45), as well as endocannabinoids, including anandamide
(39, 58). Adipocytes also store and release the fat-soluble
vitamins -tochopherol and vitamin D3 (6, 8, 10) and can
synthesize active glucocorticoids through the presence of
the type 1 form of the enzyme 11-hydroxysteroid dehy-
drogenase, with adipose tissue being an important site in
humans of the regeneration of cortisol from cortisone
(174). The CYP27B1 gene encoding the 1-hydroxylase
enzyme that catalyzes the conversion of 25-hydroxychole-
calciferol [25(OH)D3] to 1,25-dihydroxycholecalciferol
[1,25(OH)2D3] is expressed in adipocytes, with the active
vitamin D3 hormone recently having been shown to be gen-
erated in the cells (24, 112). The vitamin D receptor (VDR)
is also expressed in adipocytes, and there is growing interest
in adipose tissue as a target of 1,25(OH2)D3 action (24,
186, 196, 213).
Several major protein hormones are synthesized and se-
creted by adipocytes, the most prominent of which are lep-
tin and adiponectin (52, 158, 193, 194, 198). Both these
hormones are produced primarily, though not exclusively,
in fat cells with the circulating level of leptin being directly
related to BMI, or body fat (33, 120, 141). Correspond-
ingly, circulating adiponectin levels are reduced in obesity
(2, 85). Leptin and adiponectin each have multiple roles,
and in the case of leptin, the functions with which it is
involved include appetite, angiogenesis, and insulin secre-
tion (12, 16, 40, 64, 149, 181), while adiponectin has insu-
lin-sensitizing, anti-inflammatory, and angiogenic actions
(5, 14, 142, 222, 226). These hormones are part of the large
family of protein signals and factors released by adipocytes,
which collectively are termed “adipokines” (alternatively
“adipocytokines”). More than 100 different adipokines
have been firmly identified, but proteomic studies indicate
that there are many more, with the adipokinome perhaps
numbering several hundred entities (36, 195). The adipo-
kines have served as something of a model for the more
recent discovery of the “myokines,” protein factors secreted
from myocytes which have autocrine/paracrine actions
within skeletal muscle, or act as signals from muscle to
other tissues such as white fat (146, 148).
It is emphasized that despite adipocytes being the main site
of the synthesis of leptin and adiponectin, the proteins that
constitute the adipokinome are in practice not necessarily
selective to fat cells. Indeed, in many cases, cells in other
tissues are much more important sources of a particular
factor. The adipokines encompass a wide range of meta-
bolic functions, as illustrated in FIGURE 1, including the
regulation of appetite and energy balance, insulin sensitiv-
ity, angiogenesis, blood pressure regulation, vascular hemo-
stasis, and inflammation and the immune response (52,
158, 193, 194). There has been particular focus on the role
of various adipokines in modulating insulin sensitivity, and
tumor necrosis factor (TNF)-, leptin, adiponectin, retinol
binding protein-4 (RBP4), chemerin, and monocyte che-
moattractant protein 1 (MCP-1) are among those that been
implicated in this key action (5, 83, 84, 94, 139, 153, 172,
176, 180, 222, 223). There has also been considerable in-
terest in the adipokines involved in the inflammatory re-
sponse, this reflecting the link between inflammation in ad-
ipose tissue and the development of obesity-associated dis-
eases (80, 81, 158, 167, 198). Adipocytes synthesize and
secrete a number of classical cytokines and chemokines,
including TNF-, IL-1, IL-6, IL-8, IL-10, MCP-1, and
macrophage migration inhibitory factor (MIF) (see Refs.
34, 158, 198). Other adipokines linked to the inflammatory
response include the angiogenic factor, vascular endothelial
growth factor (VEGF), nerve growth factor (NGF), and the
acute phase protein plasminogen activator inhibitor-1 (PAI-
1). The expression and release of a number of inflamma-
tion-related adipokines rise markedly in obesity (80, 158,
198), the notable exception being adiponectin, the produc-
tion of which falls (2, 85).
Appetite and
energy balance
Inflammation
and immunity
Insulin sensitivity and
glucose homeostasis Angiogenesis
Nutrient transport Blood pressure
Lipid metabolism Vascular haemostasis
FIGURE 1. Illustration of the major physiological and metabolic
processes with which adipose tissue is involved through the secre-
tion of various adipokines from adipocytes. The interactions may be
autocrine, paracrine, or endocrine.
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The extensive number and range of adipokines implicate
adipocytes in multiple interactions within adipose tissue,
through both autocrine and paracrine mechanisms. There is
also considerable communication from adipose tissue to
other tissues via the endocrine actions of specific adipo-
kines, particularly leptin and adiponectin, and bidirectional
cross-talk is evident, for example, from skeletal muscle
through IL-6 (147, 195).
III. HYPOXIA IN ADIPOSE TISSUE
A. Theoretical Basis for Hypoxia
A central question in adipocyte biology is why the produc-
tion and release of many inflammation-related adipokines
increases in obesity and an inflammatory state develops in
the tissue. The initial proposition that adipose tissue depots
are hypoxic as tissue mass expands, clusters of adipocytes
becoming distant from the vasculature, with this initiating
the inflammatory process, was based on the following a
priori propositions (198): 1) despite the substantial expan-
sion of adipose tissue mass in obesity, the proportion of the
cardiac output and the extent of the blood flow to the tissue
are not increased (7, 93, 202); 2) while blood flow to adi-
pose tissue rises postprandially in lean subjects, it does not
increase in the obese (60, 95); and 3) large adipocytes,
which may be up to 150–200 m in diameter (182), are
larger than the normal diffusion distance of O2 of 100–200
m (13). It is emphasized that in some tissues and situations
the PO2 may be close to zero at only 100 m from the
vasculature (13, 48, 55).
The concept that the development of hypoxia underpins the
initiation and progression of the inflammatory response in
adipose tissue in obesity relates primarily to the direct ef-
fects of a low PO2. Alternative mechanisms for the develop-
ment of inflammation include endoplasmic reticulum stress
(61) and oxidative stress (86). In addition, it is increasingly
evident that the gut microbiota play an important role in the
inflammatory response (18, 62, 124). Hypoxia can under-
pin both oxidative and endoplasmic reticulum stress (21,
79, 104), providing additional routes by which low O2 ten-
sion can lead to adipose tissue dysfunction.
B. Blood Flow and Oxygenation of Adipose
Tissue
Hypoxia and the physiological challenges that this imposes
are traditionally associated with exposure, whether acute or
chronic, to high altitude or the deep seas. Local tissue hyp-
oxia is also evident in certain pathological situations, in-
cluding wound healing, ischemic disorders, psoriasis, and
obstructive sleep apnea as well as in tumors (13, 179). In the
case of solid tumors, the interstitial partial pressure of O2
may be so low that the cells in the center are essentially
anoxic, requiring major metabolic adaptations (13, 179).
The O2 tension in solid tumors can range from 10 mmHg
down to almost zero; this compares with a PO2 in arterial
blood of 104 mmHg, while the general level of tissue oxy-
genation is of the order of 40–50 mmHg (13, 15, 78). Some
tissues, in addition to tumors, may have a lower PO2 than
the general level, including the retina, thymus, and brain
which have reported values of 2–15, 10, and 0.4–10
mmHg, respectively (15, 41, 227); this is summarized in
TABLE 1. Cartilage is also markedly hypoxic, with low PO2
levels being particularly evident in rheumatoid arthritis (46,
117, 119).
White adipose depots are variously described as being
“poorly” (71) to “well” vascularized (188). To some extent
this depends on the perspective that is applied, particularly
Table 1. Oxygen level in white adipose tissue and other tissues
Tissue PO2, mmHg Reference Nos.
Inspired air (at sea level) 160 see 11
Alveolar blood from lungs 104 see 13
General tissue oxygenation 40–50 see 78
Brain 0.4–8 41
Retina 2–25 227
Spleen 16 15
Thymus 10 15
Tumors 1–10 see 13
White adipose tissue, lean mice 47.9 224
White adipose tissue, obese mice 15.2 224
White adipose tissue, humans (I) lean 55.4/obese 44.7 144
White adipose tissue, humans (II) lean 46.8/obese 67.4 60
PO2, oxygen level. Examples are of tissues where hypoxia is evident, including data on white adipose tissue from
lean and obese mice and humans.
PAUL TRAYHURN
4 Physiol Rev • VOL 93 • JANUARY 2013 • www.prv.org
if the reference point is brown adipose tissue. For example,
in rats acclimated to the cold in which nonshivering ther-
mogenesis is maximally activated, up to one-third of the
total cardiac output may be channelled to brown fat (at
1% of body weight); compared with this, the maximal
blood flow to white adipose depots is small (49, 50, 189).
Oxygen extraction from the vascular network of brown
adipose tissue is almost total during maximal rates of ther-
mogenesis, but such extremes of O2 utilization would not
occur with white fat (49, 50, 189). Capillary density is
lower in adipose tissue of obese humans compared with
lean subjects (144, 185), and this is the case in both visceral
and subcutaneous depots (137). Interestingly, while in lean
humans the density is greater in the visceral fat than the
subcutaneous, there is no difference between the two depots
in the obese (137). Reduced capillary density in adipose
tissue of the obese is accompanied by the presence of larger
vessels (185).
As noted above, the blood flow to white adipose tissue in
obese humans is not increased relative to lean individuals
(7, 92, 93, 202). This is also the case for both blood flow
and the proportion of cardiac output for obese mice and
rats compared with their lean siblings (79, 189, 212). In
addition, an early study on dogs observed an inverse rela-
tionship between fat cell size and blood flow to adipose
tissue (37). While these observations on blood flow suggest
that the supply of O2 to adipose tissue may be restricted in
obesity, they do not demonstrate hypoxia per se. This has
been directly addressed recently in seminal studies on
mouse models of obesity, both by the use of the “Hypoxy-
probe” marker system and by direct measurements of O2
tension (79, 159, 224). Three different types of obese mouse
have been employed in these studies: ob/ob and KKAy mu-
tants as well as mice with obesity induced by the consump-
tion of a high-fat diet. The Hypoxyprobe investigations,
using the hypoxia marker pimonidazole with either immu-
nostaining or western blotting, have demonstrated hypoxia
in epididymal and parametrial adipose tissue depots of the
obese animals (79, 159, 224).
Immunostaining also demonstrates that hypoxic areas
within adipose tissue are colocalized with macrophages,
indicating that there is an association between low PO2 and
the accumulation of immune cells (159). This suggests an
immediate link between hypoxia and the inflammatory re-
sponse in adipose tissue. However, the recruitment of mac-
rophages may not necessarily reflect inflammation per se,
but rather the need to remove dead and necrotic adipocytes
(31). This may link hypoxia to apoptosis and cell survival in
adipose tissue.
Direct measurements of O2 tension in adipose depots with
fiber-optic O2 sensors have similarly recorded hypoxia, in
the form of a markedly lower PO2, in adipose tissue (includ-
ing epididymal and retroperitoneal depots) of the obese
mice (159, 224). A PO2 of 48 mmHg was recorded in the
white fat of lean mice, a level that is similar to the general
level of tissue oxygenation (see TABLE 1). Importantly, for
obese mice, the PO2 was threefold lower at 15.2 mmHg
(224). Thus there is strong, direct evidence of hypoxia in
adipose tissue in rodent obesity. Other, more indirect, indi-
cators of hypoxia in mouse fat depots have also been noted,
including raised lactate levels and the increased expression
of hypoxia-sensitive genes such as SLC2A1 (facilitative glu-
cose transporter 1, GLUT1), leptin (LEP), and PAI-1 (72,
79, 224). However, since the expression of these genes in
vivo may be influenced by multiple factors, increased levels
of their mRNAs cannot necessarily be taken to indicate
hypoxia.
In the case of humans, in addition to the blood flow data
and reduced capillary density, there is also direct evidence
of relative hypoxia in adipose tissue in obesity. A study
during surgery showed that the PO2 in subcutaneous adi-
pose tissue of the upper arm is lower in obese than in lean
subjects, the difference being 20 mmHg (93). A further
study employing measurements with an O2 electrode has
also indicated that the PO2 in adipose tissue of overweight/
obese subjects is lower than that in the lean; obese 47
mmHg vs. lean 55 mmHg (144). Furthermore, an inverse
relationship between percent body fat and PO2 in the tissue
is apparent, together with evidence for macrophage accu-
mulation as the oxygenation level decreases (144). The dif-
ferences in PO2 between lean and overweight/obese subjects
in this study are not large, however, and certainly less than
that between lean and obese mice.
Contrasting results have recently been reported in which the
PO2 in adipose tissue of obese subjects was found to be
higher rather than lower than in the lean (60). This is par-
ticularly surprising since the fasting blood flow to adipose
tissue was reduced in the obese relative to the lean in this
study, and the obese did not exhibit the postprandial in-
crease in flow that occurs with the lean (60). Furthermore,
in vivo measurements of O2 consumption for the abdomi-
nal subcutaneous adipose tissue, as well as markers of mi-
tochondrial function, were lower in the obese, as was the
degree of capillarization. It is difficult to satisfactorily rec-
oncile the apparent hyperoxia noted in this study with pre-
vious work; possible explanations for the discrepancy in-
clude differences in the nature of the groups investigated
(such as the stage of obesity) and differences in the tech-
niques employed (O2 electrode versus optochemical mea-
surement). There is also the possibility of a local response to
the perfusion fluid containing ethanol employed in the re-
cent, conflicting study (60).
Overall, the balance of evidence, particularly from experi-
mental animals, strongly indicates that hypoxia occurs in
adipose tissue depots in obesity.
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IV. HYPOXIA AND ADIPOCYTE GENE
EXPRESSION
A. HIF-1 Transcription Factor
The demonstration that white adipose tissue is hypoxic in
obese animals has led to a series of studies examining the
effects of low O2 tension on the cellular function of adi-
pocytes. The focus of the early studies has been on the
expression of specific adipokine genes, particularly those
linked to inflammation and angiogenesis. Both rodent, pri-
marily the classical 3T3-L1 cell line, and human adipocytes
have been employed. A significant question in such studies
is whether hypoxia-induced alterations in adipokine pro-
duction are mediated by hypoxia-inducible factor 1 (HIF-
1), which is regarded as the key transcription factor in sig-
naling the cellular response to low PO2, and frequently de-
scribed as “the master regulator of O2 homeostasis” (179).
HIF-1, and the other transcription factors that regulate the
molecular response to hypoxia, have been the subject of a
number of excellent reviews (13, 32, 78, 96, 156, 165, 177),
and only an outline will be presented here.
HIF-1 is a heterodimer composed of  and  subunits, with
HIF-1 being constitutively expressed and insensitive to the
prevailing level of O2 (13, 179). The functional transcrip-
tion factor is recruited under conditions of low O2 tension
through the stabilization of the HIF-1 subunit, this sub-
unit operating in effect as the molecular O2 sensor of a cell.
HIF-1 is constantly synthesized in the presence of O2 and
rapidly degraded through the 26S proteosomal system. This
involves activated prolyl hydroxylase domain dioxyge-
nases, which hydroxylate HIF-1, thereby providing sites
for the binding of the von Hippel-Lindau protein (90, 91).
Following further hydroxylation, the presence of the von
Hippel-Lindau protein enables ubiquitination of the com-
plex and the subsequent targeting of HIF-1 to proteo-
somal degradation. The prolyl hydroxylase domain en-
zymes are inactivated when O2 tension is low, with the
result that HIF-1 is stabilized since the von Hippel-Lindau
is unable to bind.
Chemical hypoxia mimetics, such as cobalt chloride and
desferrioxamine, stabilize HIF-1 in the presence of normal
levels of O2 through inhibition of the prolyl hydroxylase
domain enzymes, and incubation with these compounds is
frequently employed to determine whether the expression
of a particular hypoxia-sensitive gene is regulated through
HIF-1 (116, 200, 209, 210). The expression of in excess of
70 genes is understood to be directly regulated by HIF-1,
following the binding of the transcription factor to cis-act-
ing response elements (179). These genes encode proteins
involved in a wide range of cellular functions, including
glucose utilization, angiogenesis, apoptosis, extracellular
matrix remodeling, and inflammation. Examples of specific
genes well-recognized to be transcriptionally regulated by
HIF-1 include GLUT1, VEGF, and LEP (179).
In addition to HIF-1, there are also HIF-2 and HIF-3
subunits that are the product of different genes, but their
role in the response to hypoxia appears less extensive than
HIF-1, and they have been much less studied (96, 165).
HIF-2, formed from HIF-1 and HIF-2, appears to be
more tissue-specific than HIF-1, and it is suggested that it
may respond to different levels of O2 (145). The HIFs are
not, however, the only transcription factors that signal the
hypoxic response; several others are recognized, including
NF-B, cAMP response element-binding protein (CREB),
and CHOP/GADD153 (C/EBP homologous protein also
identified as growth arrest and DNA damage 153) (21, 35,
96, 135). In practice, there appears to be overlap and cross-
talk between different factors, particularly in relation to
inflammation and immunity, with NF-B, for example, be-
ing a transcriptional activator of HIF-1 (164, 199).
HIF-1 subunits have been directly linked to adiposity, as
well as to the response to hypoxia, with increased levels of
HIF-1 being evident in adipose tissue of obese mice (72,
224). Transgenic mice in which HIF-1 is selectively lack-
ing in adipose tissue show reduced weight gain relative to
wild-type controls and resist the development of obesity when
fed a high-fat diet (109). They also exhibit reduced energy
expenditure and adipocyte size. Genetic ablation of HIF-1 in
mouse embryonic fibroblasts leads to a loss of the inhibitory
effect of hypoxia on their differentiation into adipocytes, indi-
cating that HIF-1 is involved in the inhibition of adipogenesis
by low O2 tension (229), as discussed in section VII. On the
other hand, transgenic overexpression of HIF-1 in adipose
tissue leads to elevated body fat on a normal diet and increased
obesity on a high-fat diet, and these changes are accompanied
by larger adipocytes (231).
B. Adipokine Expression and Secretion
A key early study on the effects of hypoxia on adipokine
production, which predated the in vivo observations of ad-
ipose tissue hypoxia in obesity, was that of Lolmède et al.
(116). These authors examined the effects of low PO2 (5%
O2) and the mimetics cobalt chloride and desferrioxamine
on the expression and release of several angiogenesis-re-
lated factors in 3T3-F442A adipocytes. HIF-1 levels in-
creased, indicating that murine adipocytes are able to re-
cruit the key hypoxia transcription factor, and the produc-
tion of leptin, VEGF, and the matrix metalloproteinases
MMP2 and MMP9, were each augmented under hypoxic
conditions (116). These results demonstrate that hypoxia is
markedly proangiogenic in murine fat cells.
A further key study showed that hypoxia inhibits the ex-
pression and secretion of the major adipocyte hormone adi-
ponectin in 3T3-L1 cells, together with a stimulation of
PAI-1 production (23). Since, as noted above, adiponectin
has both anti-inflammatory and insulin-sensitizing actions,
and may act as an angiogenesis inhibitor (14), the hypoxia-
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induced fall in the production of this hormone would be
expected to be both pro-inflammatory and pro-angiogenic,
while potentially compromising insulin sensitivity (5, 222).
Several other studies have examined the effects of hypoxia
on the expression of selected genes in murine adipocytes. In
addition to those already mentioned, included in the list of
those adipokine genes whose expression is increased by low
O2 tension are IL-6, MIF, NAMPT (visfatin), and APLN
(apelin) (57, 72, 175, 224). The majority of studies have
focused on gene expression, and data are not always avail-
able for the secretion of the adipokine protein. Neverthe-
less, in those cases where the release of an adipokine into the
culture medium has been investigated, the changes observed
parallel those at the gene expression level.
The effects of hypoxia on adipokine production are not spe-
cific to rodent fat cells. Several candidate gene studies have
been conducted on human adipocytes, either fibroblastic prea-
dipocytes differentiated in culture to mature fat cells or cells of
the Simpson-Golabi-Beymel (SGBS) strain (204). The out-
come of these studies is generally similar to those obtained on
rodent cells. Thus the expression of the LEP, VEGF, IL6,
PAI1, MIF, CFD (adipsin, or complement factor D) and an-
giopoietin-like protein 4 (ANGPTL4) genes is upregulated by
hypoxia, while adiponectin (ADIPOQ) and haptoglobin (HP)
expression is decreased (206). Furthermore, HIF-1 levels rise,
indicating that the transcription factor subunit is stabilized
under conditions of low O2 in human, as in murine, adipocytes
(72, 118, 206). For those adipokines where the secretion of the
protein into the medium has been determined, which include
leptin, adiponectin, IL-6, VEGF, PAI-1, and Angptl4, the
changes observed parallel those at the level of gene expression
(59, 118, 206); the effect of hypoxia on the secretion of key
adipokines by human adipocytes is illustrated in FIGURE 2. As
with murine cells, incubation with cobalt chloride indicates
that the hypoxia-dependent transcription of genes such as
LEP,VEGF,PAI-1,MIF,HP, andADIPOQ is transcription-
ally regulated through HIF-1 in human adipocytes (206). In
contrast, IL-6 expression and secretion appear to be indepen-
dent of HIF-1, at least in human adipocytes, and other tran-
scription factors, particularly NF-B, are likely to be involved
(206).
Almost all reports to date of the effects on hypoxia on the
production of selected adipokines have focused on the conse-
quences of low PO2 as the sole modulator. The potential inter-
action between hypoxia and other factors, including the re-
sponse to specific hormones and nutrients, that regulate or
influence adipokine expression and secretion have been little
considered. An example of such interactions in other cell sys-
tems is the potentiation of the hypoxia-induced expression of
VEGF by arachidonic acid in mouse embryonic stem cells
(110). Synergistic effects of fatty acids (such as arachidonic
and lauric acid) and hypoxia on the secretion of Angptl4 by
human adipocytes have been noted, both factors alone stimu-
lating production of this adipokine (59). The potential for
interaction between lipids and low O2 tension in modulating
adipose tissue function is strong, given the lipid-rich environ-
ment of the tissue and the importance of specific fatty acids in
inflammation and insulin resistance.
Of major interest in the context of interactions, hypoxia has
recently been reported to reduce the response of adipocytes to
TNF-, the stimulatory effect of the cytokine on MCP-1 re-
lease being reduced through a downregulation of the NF-B
signaling pathway (47). This appears to be linked to a decrease
in TNF receptor 1 (TNF-R1) expression and indicates an at-
tenuated response to inflammatory stimuli which may reflect a
counterregulatory process (47). These observations suggest
that the way in which hypoxia interacts with regulatory sys-
tems may be complex, and in some cases counterintuitive.
C. Hypoxia and Global Gene Expression
The majority of studies, whether on rodent or human adi-
pocytes, have employed a candidate gene approach with the
focus on specific adipokines, as described above. PCR ar-
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FIGURE 2. Example of the effects of hypoxia on the secretion of key adipokines by human adipocytes in cell
culture. The data are derived from studies in which adipocytes were incubated in either 21% or 1% O2 for 24 h
(54, 188). The results are means SE (bars; 6 observations per group), and for each adipokine, the difference
between the hypoxic and control cells is statistically significant (P  0.01 or better).
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rays have also been utilized in which some 85 genes associ-
ated with the hypoxia-signaling pathway were simultane-
ously probed in human fat cells exposed to 1% O2 for 24 h
(208). The arrays showed that a specific member of the
metallothionein gene family, metallothionein-3 (MT3), is
strongly induced by hypoxia, induction being transcription-
ally regulated through HIF-1. Indeed, there was a 600-
fold increase in MT3 mRNA level, although such an appar-
ently large response reflects, to some extent, the fact that
expression is minimal in adipocytes incubated under nor-
moxic conditions (208). The metallothioneins are low mo-
lecular weight (6,000 Mr) cysteine-rich, metal-binding
proteins, with several presumed functions which include
angiogenesis and antioxidant defense (129, 150, 230). A
proangiogenic role in adipose tissue would be consistent
with the major induction of MT3 expression by hypoxia.
Hypoxia-induced expression of the MT3 gene was first re-
ported in human astrocytes where it was suggested that
MT3 acts to protect the brain from hypoxic damage (187).
A protective action, as well as a proangiogenic role, could
similarly underlie the induction of MT3 expression in adi-
pocytes by low PO2.
UCP2 (uncoupling protein-2), CAT, and GPX1 are among
the genes that the PCR arrays suggested are downregulated
by exposure to low O2 tension (208). The second two en-
code catalase and glutathione peroxidase 1, respectively,
which are “protective” enzymes involved in oxidative stress
and the breakdown of hydrogen peroxidase. PCR arrays are
themselves restricted in the number of genes whose expres-
sion can be simultaneously probed, and they involve selec-
tivity in what to include; 100 genes in the reported study
(208). The effect of hypoxia on global gene expression in
human adipocytes has recently been examined using DNA
microarrays. In one study, which employed SGBS adi-
pocytes (day 10 postdifferentiation), the expression of just
over 500 genes was found to be modulated by exposure to
1% O2 for 16 h (56). Major cellular functions altered by
low O2 tension included glycolysis, the regulation of cell
movement and migration, and the response to nutrient lev-
els (56). However, surprisingly the expression of genes di-
rectly associated with inflammation was not generally up-
regulated by hypoxia in this study. Nevertheless, some in-
dividual inflammation-related genes, such as VEGFA,
exhibited increased expression.
In a study from the author’s group with adipocytes derived
from fibroblastic preadipocytes from normal subjects and
employing stringent inclusion criteria in the arrays (2.0-
fold change in mRNA level, P  0.01), as many as 1,300
genes were found to be differentially expressed in response
to hypoxia (1% O2 for 24 h) (126). Of these, half were
upregulated (including LEP, IL6, and VEGF) and 650
downregulated (including ADIPOQ and UCP2). Major
genes not previously identified as hypoxia sensitive in adi-
pocytes included AQP3 (aquaporin 3), FABP3 and FABP5
(which encode fatty acid binding proteins), and PPARGC1A.
PPARGC1A encodes the PPAR coactivator 1, PGC-1,
and downregulation of a number of genes controlled by this
factor was observed. Bioinformatic analysis indicated that
several pathways and functions are modulated by hypoxia,
including glucose utilization, lipid oxidation, and cell
death. Network analysis points to a marked downregula-
tion of PGC-1 and p38/ mitogen-activated protein kinase
(MAPK) signaling in the adipocytes (126).
Included in the genes whose expression was shown on mi-
croarrays to be upregulated by hypoxia in human adi-
pocytes is CCL28 (CC-chemokine ligand 28), which has
recently been reported to be induced by low O2 tension in
tumors, promoting angiogenesis and tumor immune toler-
ance (42). Induction of CCL28 expression in adipocytes by
hypoxia may have a similar function in adipose tissue, par-
ticularly given the parallels between expanding adipose tis-
sue and tumor growth. These parallels include an increasing
tissue mass with detrimental consequences for the organ-
ism, together with the stimulation of angiogenesis and a
switch from oxidative to anaerobic metabolism.
Overall, despite some specific differences, the published mi-
croarray studies indicate that hypoxia has pervasive effects
on gene expression in adipocytes; FIGURE 3 illustrates some
of the key genes whose expression is modulated by low O2
tension in adipocytes.
V. SUBSTRATE AND GENERAL
METABOLISM
A. Glucose Utilization
As noted above, microarray studies suggest that glucose
utilization through the glycolytic pathway is likely to be
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FIGURE 3. Illustration of the effects of hypoxia on the expression of
key genes in human adipocytes (1 increased,2 decreased expres-
sion in response to hypoxia). Genes encoding both adipokines and
proteins involved in general cellular metabolism are shown. The
commonly used, or protein, name rather than the gene name is
given for clarity.
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strongly upregulated in adipocytes by hypoxia (56, 126).
This represents, of course, a well-recognized cellular re-
sponse to low O2 tension, reflecting a switch from aerobic
to anaerobic metabolism. Such changes are particularly ev-
ident in tumors that exhibit markedly elevated rates of gly-
colysis (13, 78, 125). Genes in the glycolytic pathway
whose expression has been shown by either PCR arrays or
microarrays to be upregulated in adipocytes in response to
hypoxia include HK2 (hexokinase 2), PFKP (phosphofruc-
tokinase, platelet), and GPI (glucose-6-phosphate isomer-
ase) (56, 126, 208). Elevated levels of key glycolytic en-
zymes in lysates of 3T3-L1 adipocytes have also been dem-
onstrated by proteome analysis (26).
Increased rates of glucose utilization through glycolysis im-
plies increased hexose transport. The facilitative trans-
porter GLUT1, responsible for basal glucose uptake in
many cells, is highly sensitive to hypoxia (179); indeed,
induction of its expression is frequently utilized as a marker
for the cellular response to low PO2. GLUT1 gene expres-
sion is markedly increased in adipocytes, both murine and
human, in response to hypoxia (23, 79, 116, 175, 206,
224), and this is accompanied by a substantial increase in
GLUT1 protein (217). GLUT1 is not the only facilitative
glucose transporter in white adipocytes, however, with sev-
eral other GLUTs being expressed. Transcripts for GLUT3,
GLUT5, GLUT10, and GLUT12 are evident in human adi-
pocytes, as well as GLUT1 and the insulin-sensitive trans-
porter GLUT4 (215, 217).
Of the various transporters, GLUT1, GLUT3, and GLUT5
have each been shown to be upregulated in terms of gene
expression in response to hypoxia, with there being no re-
sponse to low PO2 in the case of GLUT4, GLUT10, and
GLUT12, at least over periods of up to 24 h (217). How-
ever, in the case of GLUT3 and GLUT5, the changes at the
transcript level appear not to be mirrored by increases in the
amount of the transporter protein. Thus GLUT1 is the key
hypoxia-inducible glucose transporter in fat cells. Intrigu-
ingly, while most studies on hypoxia in adipocytes have
employed an incubation period of 24 h or less, a study
involving longer periods of exposure to low PO2 indicated
that the increase in GLUT1 is sustained over several days,
but by 48 h there was a substantial fall in GLUT4 gene
expression (151). This observation, if mirrored at the pro-
tein level which preliminary results indicate is the case
(216), suggests that the insulin sensitivity of adipocytes in
terms of GLUT4-mediated glucose uptake may be compro-
mised by chronic exposure to hypoxia.
The increase in GLUT1 protein indicates that the capacity
for basal glucose uptake is enhanced in adipocytes, as in
other cell types, under hypoxic conditions. Functional stud-
ies using 2-deoxy-D-glucose have demonstrated that glucose
uptake is indeed raised on exposure to hypoxia. This in-
creased uptake is blocked in the presence of cytochalasin B,
indicating that it is transporter mediated (160, 217). Inter-
estingly, transgenic mice with a selective knockdown of
HIF-1 in adipose tissue exhibit a decrease in 2-deoxy-D-
glucose uptake in their adipocytes, and this is accompanied
by a reduction in GLUT1 and GLUT4 gene expression
(109). Furthermore, knockdown of HIF-1 in 3T3-L1 adi-
pocytes has been shown to result in a fall in GLUT1 and
GLUT4 protein (109). These observations highlight the im-
portance of the HIF-1 system in modulating glucose uptake
in adipose tissue in response to hypoxia.
A corollary of increased glucose uptake and catabolism
through the glycolytic pathway is that lactate production
would be expected to rise, as is well-documented in tumors
(55). Indeed, lactate release by adipocytes (murine and hu-
man) increases markedly under hypoxic conditions (116,
152), and lactate levels are elevated in white adipose tissue
of obese mice (79). Lactate is transported across cell mem-
branes by specific proton-linked monocarboxylate trans-
porters, the MCTs (67–69). TheMCT1,MCT2, andMCT4
genes are each expressed in human adipocytes, and hypoxia
leads to increased expression of both MCT1 and MCT4,
changes which appear to be transcriptionally regulated by
HIF-1; however, only MCT1 appears to be increased at the
protein level (152). Thus the rise in lactate production un-
der hypoxic conditions involves the recruitment of MCT1
for removal of the monocarboxylate from adipocytes.
Lactate is increasingly recognized as an important meta-
bolic signal and not simply the end product of the anaerobic
catabolism of glucose (166). Functions attributed to lactate
include the stimulation of inflammation in macrophages
and L6 cells (70, 171), the induction of insulin resistance in
muscle (25), and as an inhibitor of lipolysis in adipocytes
(114). Recent evidence suggests that the inhibition of lipol-
ysis by lactate, which is through a specific G protein-cou-
pled receptor, GPR81, mediates the classical antilipolytic
action of insulin (1, 166). White adipose tissue is an impor-
tant site of lactate production, the amount released increas-
ing in obesity (38, 79, 224). There is a direct correlation
between fat cell size and the proportion of glucose that is
converted to lactate, with up to 70% of the glucose used by
adipocytes being metabolized to lactate in the obese (38,
123).
The high lactate production by adipose tissue in obesity is
likely to be a direct reflection of the hypoxia in the tissue. A
greater inhibition of lipolysis and an accentuation of the
antilipolytic effect of insulin might be expected as one of the
implications of the elevated lactate release. However, insu-
lin resistance in adipose tissue is a characteristic of the obese
state (103), potentially as a direct consequence of hypoxia,
and as such, the lactate-mediated antilipolytic of insulin
may be attenuated (see next section). A recent clinical study
has in fact reported that the ability of insulin to inhibit
lipolysis is directly correlated with the O2 tension within
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white fat (143). Thus adipose tissue hypoxia may impair the
antilipolytic action of insulin and dysregulate the local lac-
tate autocrine/paracrine loop in the tissue (166).
B. Insulin Sensitivity
A decline in insulin sensitivity is widely recognized to occur
in obesity (82, 103, 105). Reference has already been made
to the fall in GLUT4 production in adipocytes following
prolonged exposure to hypoxia and the potential implica-
tions of this for insulin-stimulated glucose uptake. Whether
there is also a decrease in the translocation of GLUT4 to the
plasma membrane in response to insulin is unclear. Changes
in the production of specific adipokines in low PO2 are also
likely to impact on insulin sensitivity, both locally within
adipose tissue and distally in other tissues. For example, the
reduction in adiponectin secretion (23, 206), given the in-
sulin-sensitizing action of this hormone, may lead to insulin
resistance. Similarly, the increase in the synthesis and re-
lease of IL-6 may contribute to resistance, given the link
between this cytokine and insulin sensitivity (107, 108,
170).
Importantly, a direct effect of hypoxia in inducing marked
insulin resistance in 3T3-L1 adipocytes has been docu-
mented (160, 225). Within 24 h of exposure to low O2
tension, 2-deoxy-D-glucose experiments indicate that there
is an essentially complete loss of insulin-stimulated glucose
uptake. This is a consequence of an inhibition in the insulin-
induced phosphorylation of the insulin receptor- and of
insulin receptor substrate 1 (IRS-1), together with impair-
ment of other components of the insulin signaling pathway
in adipocytes (160, 225). The downregulation of insulin
signaling in response to hypoxia is driven by both HIF-1
and HIF-2, since overexpression of HIF-1 or HIF-2mim-
ics the effects of low PO2 (160). Correspondingly, inhibition
of these two HIF subunits attenuates the hypoxia-induced
downregulation of the insulin signaling pathway. Collec-
tively, hypoxia may lead to marked insulin resistance in
adipose tissue through multiple, and potentially additive,
routes: the insulin signaling pathway, the synthesis of
GLUT4, and alterations in the production of adipokines
linked to insulin sensitivity. Indeed, hypoxia may well play
a central role in the development of insulin resistance in the
tissue in obesity.
An impaired response to hypoxia has recently been reported
in mature subcutaneous adipocytes of diabetic db/db mice
compared with their wild-type siblings (77). VEGF and
heme oxygenase 1 (HMOX1) gene expression was not stim-
ulated by hypoxia in the adipocytes from the mutant mice.
However, whether this is directly related to the diabetic
state of the donor mice, is a consequence of the leptin re-
ceptor mutation, or is due to differences in fat cell size
between the different groups of animals is not clear. Fur-
thermore, the overall response to low O2 tension in the
adipocytes from the control mice was limited, with no effect
on the expression of several adipokines being evident, in-
cluding leptin (77).
In a study on obese humans, higher HIF-1 mRNA levels
have been observed in omental, though not subcutaneous,
adipose tissue of subjects who were insulin resistant relative
to those who were insulin sensitive, suggesting that the tis-
sue of the former group is more hypoxic (102). This differ-
ence was associated with increased macrophage accumula-
tion in the tissue, together with increased expression of
factors that act as chemoattractants to immune cells (102).
Caution has, however, to be exercised in interpreting
HIF-1 mRNA levels, since they may not correlate with
changes in the amount of the functional HIF-1 protein
(197).
C. Lipid and Oxidative Metabolism
The increased glucose utilization through the glycolytic
pathway in hypoxia is a reflection of the absolute require-
ment for increased anaerobic metabolism in response to the
lack of O2. The corollary is that substrate flux through lipid
oxidation, and indeed all oxidative metabolism, will fall.
Analysis of microarray data indicates that the expression of
genes associated with lipolysis and lipid oxidation is indeed
strongly altered by hypoxia (126). Similarly, several genes
encoding proteins involved in oxidative phosphorylation,
including ATP5D (ATP synthase, H transporting, mito-
chondrial F1 complex, delta subunit), COX5A (cyto-
chrome c oxidase subunit Va) and CYTB (mitochondrially
encoded cytochrome b) are downregulated in human adi-
pocytes following exposure to a low PO2 (126). One of the
most strongly downregulated genes is PPARGC1A, the en-
coded protein PGC-1 being linked with mitochondrial
biogenesis (191).
One of the key adaptations to reduced PO2 at the mitochon-
drial level is a HIF-1-dependent switch at complex IV from
the COX4–1 to the COX4–2 subunit of cytochrome c ox-
idase (53, 178). This switch, which has been demonstrated
in several cell types and is catalyzed by the mitochondrial
protease LON, has been shown by gain-of-function and
loss-of-function studies to result in an increase in the effi-
ciency of oxidative phosphorylation (53, 178). There is,
however, a penalty for this change in that the generation of
reactive oxygen species rises. In studies on human adi-
pocytes, an increase in COX4–2 and LON mRNA level,
together with a fall in COX4–1 mRNA, has been noted in
response to hypoxia, consistent with a switch towards more
tightly coupled oxidative phosphorylation (Wang and
Trayhurn, unpublished data). In contrast, a decrease in
COX4–2, with no change in COX4–1, expression has re-
cently been noted in mouse adipocytes (109); it is unclear
why different responses have been observed between hu-
man and murine cells.
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Although basal lipolysis in murine adipocytes, as deter-
mined by glycerol release, was originally reported to be
unaltered by hypoxia (116), other studies have suggested
that it is increased (225). An increase would be consistent
with hypoxia-induced insulin resistance leading to a loss of
the antilipolytic action of the hormone. Fatty acid uptake
by adipocytes, on the other hand, is decreased by hypoxia
(225). This, together with increased lipolysis, may underlie
the elevation of plasma free fatty acid levels in obesity (51).
D. Extracellular Matrix and Fibrosis
There is growing recognition of the importance of the ex-
tracellular matrix in the architecture and function of adi-
pose tissue, and the consequences of dysregulation for tissue
malfunction (73, 98, 122). It is suggested that the energy
cost to adipocytes of maintaining, and remodeling, the ex-
tracellular matrix is considerable (122). Fibrosis develops in
adipose tissue in obesity (65, 73), and a model has recently
been suggested in which adipose tissue hypoxia, as one of
the earliest events in adipose tissue dysfunction, induces a
local state of fibrosis in the tissue (65). This in turn leads to
the inflammation and the metabolic derangements linked to
obesity, particularly insulin resistance. Selective knock-
down of HIF-1 in adipose tissue is, however, reported to
have no effect on diet-induced inflammation and fibrosis in
the tissue (109).
Several genes associated with the extracellular matrix are
upregulated in vivo in adipose tissue of mice following
whole body exposure to hypoxia (10% O2), including
COL1A1 (collagen, type I, alpha 1) and COL3A1 (collagen,
type III, alpha 1) (65). Furthermore,50 genes in the tissue
are reported to be upregulated in a HIF-1-dependent man-
ner in transgenic HIF-1 mice, including several procolla-
gens and the enzyme lysyl oxidase (LOX) which plays a
central role in collagen cross-linking (65). Interrogation of
microarray datasets from human adipocytes indicates that
the expression of theLOX gene is stimulated by hypoxia, as
is the COL13A1 gene encoding collagen type XIII alpha
(126). Other genes functionally linked with the extracellu-
lar matrix that are regulated in adipocytes by hypoxia in-
clude the matrix metalloproteinases MMP2 and MMP9,
which are involved in matrix turnover and tissue remodel-
ing (116).
A reduction in capillary density in adipose tissue of the
obese accompanied by larger vessels has already been
noted, and it is suggested that these changes inhibit angio-
genesis and limit the expandability of adipose tissue (185).
Collagen V levels appear to be increased in adipose tissue of
the obese and are colocalized with large vessels and fibrotic
areas within the tissue; elastin, on the other hand, is de-
creased (185). In a study on collagen VI knockout mice, the
absence of this extracellular matrix protein, which is nor-
mally highly enriched in adipose tissue, was shown to result
in continued expansion of adipocytes together with multi-
ple metabolic changes, including a reduction in tissue and
systemic inflammation (98).
VI. THE SIGNIFICANCE OF DIFFERING
O2 LEVELS
In in vitro studies on the cellular response to hypoxia, it is
common to employ 1% O2 (although 2 or 5% O2 are also
sometimes used). This is considered to constitute severe
hypoxia, but is generally justified as an experimental tool to
establish “proof of principle.” However, as noted earlier,
measurements suggest that in vivo the PO2 in white adipose
tissue of obese mice is as low as 15 mmHg, which is equiv-
alent to 2% O2 (224). Thus incubating adipocytes in 1% O2
does not represent a substantial departure from the level of
oxygenation to which the cells may be subject in vivo. It
should also be noted, as discussed earlier, that physiologi-
cally several other tissues, including the retina, parts of the
brain, and tumors have a similar, or lower, O2 tension (13,
41, 227).
The PO2 in adipose tissue of lean mice, on the other hand, at
between 45 and 50 mmHg, is similar to that of the general
level of tissue oxygenation (13, 78) and is equivalent to
6.5% O2 (224). This is considerably lower than the 21%
O2 under which adipocytes, and other cells, are routinely
incubated as the reference O2 level and which is termed
“normoxia.” The effects of different levels of O2, ranging
from 21 to 1%, on the expression and secretion of adipo-
kines from human adipocytes has recently been examined
(214), and is illustrated in FIGURE 4. The results indicate
that for several adipokines there is a direct dose-dependent
effect of O2 tension, both in terms of gene expression and
the secretion of the mature protein. This is particularly ev-
ident for leptin and VEGF, and for both these adipokines,
there are marked increases in mRNA and protein release
between 21 and 10% O2, with further increases as PO2 is
decreased. For some adipokines, including leptin, the peak
response is evident at 5% O2 with little further effect at
lower O2 concentrations. The major part of the response
was generally found to be between 10 and 3% O2, which is
effectively the physiological range (214).
The effects of differing O2 concentrations on glucose up-
take and lactate efflux have also been examined, together
with the expression of their respective transporters (214).
Each of these parameters shows a similar dose-dependent
response as is found for adipokine production. However,
2-deoxy-D-glucose uptake and GLUT1 gene expression
continue to increase as O2 tension falls from 5 to 1%, indi-
cating that the demand for glucose does not appear to pla-
teau in the same manner as adipokine synthesis. Given the
evidence for the direct induction of insulin resistance in
adipocytes by exposure to 1% O2 (160, 225), an important
question is the threshold level of O2 tension at which insulin
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sensitivity is compromised and overt resistance ensues. It is
possible, of course, that insulin sensitivity is gradually mod-
ulated across the entire physiological range of O2 concen-
trations.
There are several important implications from these obser-
vations on the effect of different O2 levels. First, adipocytes
appear highly sensitive to O2 tension, their metabolic func-
tions being titrated by even relatively small changes in O2
level within the normal physiological range. Second, so-
called “normoxia” is in effect “hyperoxia,” with each of the
measured parameters being at a minimum at 21% O2; this
results in an exaggeration of the apparent scale of response
to “hypoxia.” Third, it would seem appropriate to incubate
cells at a lower PO2 than is customarily done. Indeed, there is a
question of whether some observations from cell culture stud-
ies in practice reflect a response to hyperoxia. In this regard, it
is appropriate to contrast the focus on employing “physio-
logical” conditions in in vitro work with respect to pH (7.4)
and temperature (37°C), except when these are the vari-
ables under investigation.
VII. HYPOXIA AND THE STROMAL-
VASCULAR CELLS: MACROPHAGES
AND PREADIPOCYTES
By virtue of their size, large adipocytes would be expected
to be the cells within adipose tissue that are most subject to
hypoxia. Nevertheless, the extent to which other cell types
in the tissue may be modulated by hypoxia needs to be
considered. Hypoxia has been shown to increase the secre-
tion of key cytokines, and of VEGF, from the combined
cells of the stromal-vascular fraction (SV) of human adipose
tissue (137, 161). The cytokines whose release is stimulated
include TNF-, IL-6, IL-10, and CCL-2 (MCP-1), while
increases in the expression of genes such as VEGF also
occur. Inhibition of JNK (c-Jun NH2-terminal kinase) and
p38 attenuates the hypoxia-induced increase in cytokine
secretion. The SV fraction is, of course, composed of differ-
ent types of cell, effectively all the cells within adipose tissue
with the exception of mature adipocytes. It is therefore
difficult to attribute the hypoxic response in the SV fraction
as a whole to a specific cell type. However, the effects were
reported to be enhanced in SV fractions enriched in the
macrophage marker CD14 and absent in fractions that
were CD14 depleted. This implies that macrophages are the
major source of inflammatory cytokines within the SV un-
der hypoxic conditions, as they are in normoxia (137).
Macrophages are central players in the inflammatory re-
sponse in white adipose tissue. Direct studies on macro-
phages, or macrophage cell lines, indicate that they respond
strongly to hypoxia with a stimulation of the production of
a range of cytokines and other inflammation-related factors
(111, 132, 224). In a recent study, hypoxia has been re-
ported to upregulate TLR-4 (Toll-like receptor 4) expres-
sion via HIF-1 in RAW264.7 cells, providing a mechanism
for the stimulation of the production of inflammatory me-
diators by enhancing the response to lipopolysaccharide
(100, 101). Interrogation of microarray datasets does not
suggest, however, any such hypoxia-induced upregulation
of TLR-4 expression in adipocytes.
21% ------ ------ ------ -- --
Gene expression
Adipokine secretion ↑ leptin ↓ adiponectin
Glucose utilization ↓ lactate release
15% 10% 5% 3% 1%
O2
arterial pO2
lean
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↑2-DG uptake
↑ IL6↑ LEP
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FIGURE 4. Illustration of how different levels of oxygen (between 21% and 1% O2) influence gene expression,
adipokine secretion, and the metabolic function of human adipocytes in culture. The figure is derived from data
in References 196 and 206 and shows the level of O2 at which significant changes in the given parameter are
initiated relative to the adipocytes maintained under “normoxia” (21% O2). 2-DG, 2-deoxy-D-glucose; ADIPOQ,
adiponectin; SLCA1, GLUT1; SLC16A1, MCT1.
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Preadipocytes, as the precursors of adipocytes, are key cells
within adipose tissue, and their response to hypoxic condi-
tions has been explored from different perspectives. A ma-
jor effect of low O2 tension on preadipocytes is to inhibit
their differentiation to adipocytes (21, 99, 113, 229, 233).
Expression of the PPAR nuclear transcription factor is
downregulated in preadipocytes by hypoxia, through
HIF-1, and this is likely to be the central mechanism
through which adipogenesis is inhibited when O2 tension is
reduced (99, 207, 229). PPAR expression is also inhibited
by hypoxia in mature adipocytes (79, 207), and this may be
the explanation, at least in part, for the hypoxia-induced
changes in the expression of genes such as adiponectin.
These effects may in turn involve C/EBP homologous pro-
tein (CHOP), given the role of this factor in inhibiting adi-
pocyte differentiation (87), and CHOP expression is in-
creased in adipose tissue of obese animals and in 3T3-L1
adipocytes exposed to hypoxia (79). The downregulation of
PPAR and inhibition of adipocyte differentiation in a low
O2 environment may in practice provide a brake on fat cell
recruitment in obesity. This would be consistent with the
concept that fat cell number stays constant in adult obese
(and normal weight) subjects, the number of adipocytes
being set in childhood and adolescence (184).
As well as being the precursors of mature adipocytes, prea-
dipocytes are significant inflammatory cells in their own
right, expressing and releasing a range of inflammation-
related factors, particularly in response to stimulation by
macrophage-derived mediators (27, 43, 97, 106, 136).
Hypoxia leads to the stabilization of HIF-1, leading to the
accumulation of HIF-1, in preadipocytes as in adipocytes
(118, 207). Exposure of preadipocytes to low PO2 has been
shown to modulate the expression of several genes that are
hypoxia-sensitive in adipocytes, including VEGF, FABP4
(aP2), and GLUT1, and VEGF secretion is stimulated
(207), as is the release of PAI-1, IL-4, and IL-6 (118). How-
ever, intriguingly the expression of several genes that are
hypoxia sensitive in adipocytes, including IL6 and ANG-
PTL4, are insensitive to reduced O2 tension in preadi-
pocytes. Maturation of the full cellular response to hypoxia
would seem to be dependent on adipocyte differentiation,
because of the absence (or presence) of other transcriptional
regulators of HIF-1 target genes (207).
One of the most intriguing aspects of the response of prea-
dipocytes to hypoxia relates to leptin. Preadipocytes are
considered not to express the LEP gene, expression gener-
ally occurring at around 3–4 days after the induction of
differentiation in cell culture. Indeed, the appearance of
leptin is in effect a late marker of adipocyte differentiation.
In several cell types, including trophoblast-derived BeWo
cells and breast cancer cell lines, which normally show very
little or no leptin expression, exposure to hypoxia leads to
the induction of leptin synthesis (22, 63, 127, 131, 218).
Similarly, incubation of human preadipocytes in low PO2
results in the marked induction of leptin gene expression,
and leptin is secreted into the medium (207). Thus hypoxia
turns preadipocytes into leptin-secreting endocrine cells.
However, the amount of leptin released by preadipocytes is
considerably less than by adipocytes and is unlikely to make
a significant contribution to the circulating level of the hor-
mone. Preadipocyte-derived leptin may, instead, play a spe-
cific local autocrine/paracrine role within adipose tissue.
The studies on leptin production by preadipocytes com-
pared cells incubated in 1% O2 with those under the so-
called “normoxic” conditions. As discussed above, physio-
logically the O2 tension to which cells in adipose tissue are
exposed will normally be equivalent to no more than 7%
O2. This raises the possibility that in vivo preadipocytes
constitutively synthesize leptin and secrete the hormone. If
this is the case, the cell culture studies reflect an artefactual
suppression of leptin expression as a consequence of hyper-
oxia. Examination of the response of preadipocytes to dif-
fering levels of O2, similar to the investigations on mature
adipocytes, would be of considerable interest.
VIII. CONCLUDING COMMENTS
There is now substantial evidence, both direct and indirect,
indicating that white adipose tissue depots become hypoxic
as tissue mass expands during the development of obesity.
The sheer size of large adipocytes limits the availability of
O2, especially for those fat cells that are distant from the
capillaries. The evidence for hypoxia is particularly strong
in animal models with the direct demonstration of reduced
PO2 in adipose tissue of different types of obese mouse (79,
159, 224). Similarly, much of the available data in humans,
including from studies on tissue vascularization and blood
flow as well as O2 tension, also strongly support the prop-
osition of adipose tissue hypoxia in obesity (7, 92, 93, 95,
144, 202). The recent suggestion that adipose tissue in
obese humans exhibits hyperoxia rather than hypoxia is
intriguing (60), and further investigations are warranted to
clarify the position.
Obesity has been the focus and driver of much of the inter-
est in the biology of adipose tissue over the past decade.
However, it is not the only condition in which there is a
considerable increase in adipose tissue mass, although it is
one of the most extreme. The tissue is highly dynamic in the
sense that changes in mass of an order of magnitude can
occur, and this far exceeds the alterations that take place
with other tissues (except in profound cachexia). Physiolog-
ical states where there may also be a substantial increase in
adiposity include pregnancy, in anticipation of the need to
fuel the costs of lactation, and the fattening that occurs
prehibernation and premigration for those species that un-
dergo seasonal hibernation and migration, respectively
(193). In the case of some hibernating species, such as Rich-
ardson’s ground squirrel (Spermophilus richardsonii), body
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weight may double during the 4- to 5-mo period between
the emergence from hibernation in the spring and the reen-
try into hibernation in late summer, with almost all of this
increase being due to adipose tissue (130). Whether hypoxia
develops with the rapid increase in adipose tissue mass pre-
hibernation (or premigration and during pregnancy) is a
question of some interest; there is little reason to suppose, a
priori, that reduced PO2 in the expanding tissue would be
unique to obesity.
White adipocytes exhibit extensive metabolic and func-
tional adaptations to low PO2, as illustrated in FIGURE 5.
The expression of in excess of 1,000 genes is altered, with
similar numbers being downregulated as are upregulated
(126). HIF-1 is the key transcription factor regulating the
expression of some of these genes. However, other tran-
scription factors are clearly involved in view of the large
number of genes that are hypoxia-sensitive in adipocytes.
These transcriptional regulators may include HIF-2 and
NF-B, the former having been linked with the hypoxia-
induced inhibition of insulin signaling (160), and the poten-
tial role of these and other factors in the pathways involved
in the response of adipocytes to hypoxia needs to be ex-
plored, as does the cross-talk between different signals.
Changes in the expression of some adipocyte genes over the
16- or 24-h exposure period employed in the published
microarray studies (56, 126) may, of course, be secondary
to other changes, rather than being a direct effect of low
PO2. Further interrogation of microarray datasets is likely to
yield insight into the effects of hypoxia on adipocyte func-
tion beyond the major pathways and networks that have
been identified to date.
A key metabolic change in response to low PO2 is the switch
from oxidative metabolism to anerobic glycolysis with a
marked increase in glucose uptake and utilization. This ad-
aptation to hypoxia in adipocytes is characteristic of most,
if not all, cells and has been well-documented in tumors
where the PO2 may be so low that essentially anoxic condi-
tions prevail (13, 78). One of the consequences of increased
glucose metabolism through glycolysis is a rise in lactate
release, and this may impact on the downstream processes
that are regulated by the metabolite. These may include, for
example, an augmentation of the inflammatory stimulus to
macrophages through TLR-4 signaling (171) as well as the
induction of insulin resistance in skeletal muscle (25). The
response to hypoxia that is particularly characteristic of
adipocytes relates to the production of key adipokines. The
Insulin
Expression
of ~1300 genes
FA oxidation
Glycolysis
LipidHIF-1
TFs
O2
Ion channels
GLUT1
MCT1
Lactate release
Glucose uptake
Adiponectin
Leptin
IL-6, PAI-1
angptl4, VEGF
Adipokines
Lactate
FIGURE 5. Schematic representation of the effects of hypoxia on key functions of white adipocytes. The effect
of low O2 tension on the production of selected adipokines and on glucose uptake and utilization is shown,
together with effects on other processes. FA, fatty acid; TF, transcription factors (additional to HIF-1).
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expression and secretion of both the signature adipocyte
hormones, leptin and adiponectin, are altered by low PO2,
leptin production being increased and adiponectin de-
creased (23, 116, 206). As such, hypoxia may be the prin-
cipal reason for the increase in leptin and reduction in adi-
ponectin levels in plasma in obesity. These changes in hor-
mone production would be expected to have a detrimental
impact on insulin sensitivity and to be proinflammatory.
Hypoxia induces the synthesis of several angiogenic fac-
tors by adipocytes, particularly VEGF, but also leptin
and apelin, and this reflects the classical response to low
O2 tension, with the intent of growing the capillary net-
work and thereby enhancing blood delivery and tissue
oxygenation to hypoxic areas. However, the angiogenic
stimulus is clearly unable to compensate sufficiently to
reverse the adipose tissue hypoxia. Hypoxia-independent
angiogenesis in adipose tissue has been noted in mice in
the context of acclimation to the cold (221). The general
view is that angiogenesis in adipose tissue is driven
through inflammation (219), and a broader inflamma-
tory response is evident with increased production of
specific cytokines and chemokines (79, 206, 224), and
this too is presumed to relate to the need to increase
blood flow to hypoxic tissue. Chronic inflammation, with
alterations in the production of key adipokines, is detri-
mental, however, leading to the development of the key
obesity-associated diseases (80, 167, 228). Insulin resis-
tance in adipocytes is likely to be one of the first conse-
quences of hypoxia, and there appear to be several routes
by which this can be initiated, including changes in in-
flammation-related adipokines, but most importantly
through a direct inhibition of insulin signaling (160,
225). Fibrosis is emerging as one of the defects that de-
velops in adipose tissue in obesity, and in one scenario
hypoxia is viewed as the initiating event in adipose tissue
dysfunction, followed by fibrosis and inflammation (65).
An important question physiologically is the extent to
which the O2 tension falls in adipose tissue before what
would be regarded as a hypoxic response begins to be es-
tablished in adipocytes. However, the O2 level employed in
cell culture and other in vitro studies is much higher than
the prevailing PO2 in adipose tissue, even in lean animals,
and what is apparent from dose-response data is that a
hypoxic response relative to normoxia is well-established at
physiological levels of oxygenation (214). A particularly
pertinent issue is the level of PO2 at which insulin resistance
is initiated in adipocytes.
The focus of this review has been the effects of chronic
hypoxia, but there are situations where reductions in PO2
may be intermittent. The clearest example is with ob-
structive sleep apnea, which because of recurring epi-
sodes of upper airway collapse results in bouts of inter-
mittent hypoxia (11). Obstructive sleep apnea, the prev-
alence of which is high in the obese (103), is associated
with insulin resistance, the metabolic syndrome, and car-
diovascular abnormalities (11, 89, 157). In in vivo stud-
ies, intermittent hypoxia has been found to induce insulin
resistance in mice, and this is accompanied by an upregu-
lation of leptin gene expression in adipose tissue (88,
155). Intermittent hypoxia appears to inhibit the secre-
tion of adiponectin from 3T3-L1 adipocytes in culture,
similar to the effects of chronic exposure to a low PO2,
but paradoxically ADIPOQ gene expression is upregu-
lated (121). In PC12 cells, HIF-1 levels are reported to
increase more following intermittent compared with
chronic hypoxia (133), and if this is also the case for
adipocytes, it would of interest to establish whether it is
accompanied by increased transcriptional activation of
HIF-1-sensitive genes. It is, of course, possible that inter-
mittent hypoxia during episodes of obstructive sleep ap-
nea in the obese may not impact on adipose tissue, be-
cause there is little additional effect on a tissue that is
already hypoxic.
Preventing and treating obesity has become a major public
health priority, but after several decades of increasingly
intensive research activity, progress has been very limited,
as the continuing escalation in the number of those who are
obese demonstrates. While it would be clearly desirable to
prevent obesity in the first place, this involving complex
social and cultural issues as well as biological insight, much
of the medical concern is primarily with the health conse-
quences of being obese, rather than obesity per se. Substan-
tial progress is more likely to be made in identifying suc-
cessful strategies for treating the major obesity-associated
diseases, particularly insulin resistance and the metabolic
syndrome, than with preventing obesity itself. The hypoxia
that develops in adipose tissue as the mass of the tissue
expands provides a focus for understanding and potentially
treating the disease sequelae of obesity. Reversing hypoxia,
or attenuating the O2-signaling pathways, whether through
the HIFs or other regulatory factors, presents novel oppor-
tunities and targets, providing adiposity is not itself en-
hanced.
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